Background: The efficacy and tolerability of the neuraminidase inhibitor zanamivir in the treatment of influenza have been established in an extensive programme of controlled clinical trials.
For example, in a network meta-analysis of mortality that included four trials of oseltamivir, peramivir, or zanamivir (Relenza) for the treatment of severe seasonal influenza, the impact on ...
You can access the EMC by clicking the links below. Desktop access to the EMC is via the Competition Management module, you need to make sure you have the Match Card Admin role and the relevant ...
Six of the trials were included in the meta-analysis. The studied drugs were oseltamivir (brand name, Tamiflu), peramivir (Rapivab), zanamivir (Relenza), rimantadine (Flumadine), zanamivir plus ...